Filing Flows

Filing Flows › ADC Therapeutics SA (ADCT) › How it makes money

How ADC Therapeutics SA (ADCT) makes money

ADC Therapeutics SA (ADCT) made $19.2M of revenue in the second quarter 2026 (Q2 2026), +2% from a year earlier. Product revenues, net brought in $18.6M (97%); Royalties brought in $614K (3%).

Drawing the Sankey…

ADC Therapeutics SA revenue by segment, Q2 2026ADC Therapeutics SA revenue by segment, Q2 2026Product revenues, net$18.6MRoyalties$614K
ADC Therapeutics SA: revenue by line, Q1 2025 to Q2 2026ADC Therapeutics SA: revenue by line, Q1 2025 to Q2 2026Product revenues, netLicense revenuesRoyaltiesProduct revenues, net: $18.6M latest$18.6MLicense revenues: $0 latestRoyalties: $614K latestQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Product revenues, net went from 76% of revenue in Q1 2025 to 97% in Q2 2026, the largest shift in the mix.
ADC Therapeutics SA revenue by quarterADC Therapeutics SA revenue by quarter$16.9MQ4 2024$23.0MQ1 2025$18.8MQ2 2025$16.4MQ3 2025$23.1MQ4 2025$20.9MQ1 2026$19.2MQ2 2026

Revenue by segment, Q2 2026

SegmentRevenueShareQ/QY/Y
Product revenues, net$18.6M96.8%-7%+3%
Royalties$614K3.2%-25%-19%

Where each dollar of revenue goes

LineQ2 2026% of revenue
Revenue$19.2M100.0%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q2 2026$19.2M+2%
Q1 2026$20.9M-10%
Q4 2025$23.1M+36%
Q3 2025$16.4M-11%
Q2 2025$18.8M+8%
Q1 2025$23.0M+28%
Q4 2024$16.9M+0.7%

From ADC Therapeutics SA's 10-Q filed Aug 13, 2026 (on EDGAR).

Questions

How does ADC Therapeutics SA make money?

ADC Therapeutics SA (ADCT) made $19.2M of revenue in the second quarter 2026 (Q2 2026), +2% from a year earlier. Product revenues, net brought in $18.6M (97%); Royalties brought in $614K (3%).

What is ADC Therapeutics SA's biggest business?

Product revenues, net: $18.6M in the second quarter 2026, 97% of revenue, +3% from a year earlier.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.